Module 6 – Stem cell transplantation in myeloma
Summary of module
This module describes the principles of high-dose therapy (HDT) and stem cell transplantation (SCT) as part of initial treatment.
It focuses primarily on autologous SCT and includes information about the potential risks and likely side-effects of the process and discusses related nursing care, as well as the significant role that nurses can play in supporting patients through both the procedure and recovery period.
The roles of allogeneic stem cell transplantation and tandem transplantation are also discussed.
Learning outcomes
After successfully completing this module you will be able to:
- Discuss the factors that are pertinent to treatment decisions about high-dose therapy and stem cell transplantation
- Describe the types of stem cell transplant used in myeloma
- Explain the potential risks and benefits of the different types of transplants and understand the best circumstances under which each should be recommended
- Outline the process of stem cell transplantation in myeloma and related nursing care
Study time
The following number of hours of study time is recommended for successful completion of this module:
Online learning: 5
Independent study: 5
Total hours: 10 hr